financetom
Business
financetom
/
Business
/
RBB Bancorp Q2 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBB Bancorp Q2 Earnings, Revenue Rise
Jul 21, 2025 2:15 PM

04:51 PM EDT, 07/21/2025 (MT Newswires) -- RBB Bancorp ( RBB ) reported Q2 earnings late Monday of $0.52 per diluted share, up from $0.39 a year earlier.

Analysts polled by FactSet expected $0.36.

Revenue for the quarter ended June 30, expressed as the sum of net interest income and total noninterest income, was $33.4 million, up from $26.9 million a year earlier.

Four analysts surveyed by FactSet expected $29.6 million.

Shares of RBB Bancorp ( RBB ) were up 4.1% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CleanSpark Bitcoins Mined in February Drop Sequentially
CleanSpark Bitcoins Mined in February Drop Sequentially
Mar 5, 2025
02:28 PM EST, 03/05/2025 (MT Newswires) -- CleanSpark ( CLSK ) said Wednesday it mined 624 bitcoins in February, compared with 626 reported for January, raising the calendar year total to 1,250. The company said it sold 2.73 bitcoins in February at an average price of about $95,695 per bitcoin. As of Feb. 28, CleanSpark's ( CLSK ) total bitcoin...
What's Going On With Intel Shares Wednesday?
What's Going On With Intel Shares Wednesday?
Mar 5, 2025
Intel Corporation ( INTC ) stock is moving lower on Wednesday. Weakness in the stock may be due to President Donald Trump‘s call to end the CHIPS and Science Act. What To Know: Trump, during his address to Congress on Tuesday, called for an end to the CHIPS Act, stating, your Chips Act is a horrible, horrible thing,” according to...
Hoth Therapeutics Reports HT-001 Cream Efficacy in Case Study
Hoth Therapeutics Reports HT-001 Cream Efficacy in Case Study
Mar 5, 2025
02:21 PM EST, 03/05/2025 (MT Newswires) -- Hoth Therapeutics ( HOTH ) said Wednesday its therapeutic candidate, HT-001, showed promising results in a patient with metastatic breast cancer undergoing treatment with paclitaxel, trastuzumab, and pertuzumab. The patient developed pruritic, burning red papules on the face, scalp, and upper back, a known dermatologic side effect of EGFR inhibitors, the company said....
Mars set to price $26 billion 8-part bond, highlights big M&A financing week
Mars set to price $26 billion 8-part bond, highlights big M&A financing week
Mar 5, 2025
* Mars issues 8-part bond for Kellanova ( K ) acquisition * Bond offering to raise $26 billion, bookrunners say * Mars bond deal may double M&A bond issuance for 2025, IGM reports (Updates with launch details) By Shankar Ramakrishnan March 5 (Reuters) - Family-owned candy giant Mars is set to price a $26 billion eight-part investment-grade bond offering on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved